# Elevating Impact in Global Health Innovation | InvVax

- Canonical URL: https://wefunder.com/feed/169726
- Entity ID: wefunder:feed_item:169726
- Published at: 2023-12-29 19:55:36 UTC
- Updated at: 2025-07-11 23:10:55 UTC

## Author
Arthur Young

## Subject
InvVax

## Content
It is very difficult, in this season of gladness and joy, to share with you this tragic story of a beautiful young girl, fully healthy, who perished just one day after being diagnosed with the flu.Read Article at Today.comStories like these are a sober reminder – indeed, a spark lit under me –motivating me to work double overtime to make the InvVax product a commercial reality. If there is a girl like Teresa, there are 650,000 more who succumb each year to the flu worldwide; and what is my time, my comfort, even my life in comparison? If I give it everything I have, just to save one life, wouldn’t that be a tradeoff that I would make in a heartbeat?And yet if we are successful, you and I, in bringing the InvVax flu vaccine to market, we could save the lives of millions.At InvVax, we're not merely developing a new flu vaccine; we're pioneering an innovative approach designed to outsmart the flu in all its mutating forms. Our vision is clear: to save countless lives and offer a beacon of hope through groundbreaking health solutions. Your foresight in considering this partnership positions us both at the forefront of a significant market opportunity with vast societal impact. As you contemplate the strategic addition of InvVax to your portfolio, consider the transformative potential of being part of a venture where innovation meets urgent global need. Your involvement is more than an investment; it's a powerful statement of leadership and commitment to global health.We're ready to accelerate our path to market and establish a new standard in flu prevention. With your partnership, we can expand our reach and redefine what's possible in public health. This journey promises not just substantial returns but also a lasting legacy in global health innovation.I look forward to exploring the full potential of our collaboration and am available for a detailed discussion at your earliest convenience.Best regards,Arthur YoungClick here to invest in InvVax